Marcela Maus
Director/Board Member chez 2SEVENTY BIO, INC.
Fortune : 83 471 $ au 31/03/2024
Profil
Marcela V.
Maus is the founder of Century Therapeutics, Inc. founded in 2018.
She currently holds multiple positions including Director-Cellular Immunotherapy at Massachusetts General Hospital Cancer Center, Non-Executive Director at Ichnos Sciences, Inc., Independent Director at 2seventy Bio, Inc., Associate Member at Harvard University, Massachusetts Institute of Technology, and The Ragon Institute of MGH MIT & Harvard, and Associate professor at Harvard Medical School.
She previously worked as a Director at bluebird bio, Inc. in 2021.
Dr. Maus holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from Massachusetts Institute of Technology.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
2SEVENTY BIO, INC.
0,03% | 13/06/2023 | 15 602 ( 0,03% ) | 83 471 $ | 31/03/2024 |
Postes actifs de Marcela Maus
| Sociétés | Poste | Début |
|---|---|---|
| 2SEVENTY BIO, INC. | Director/Board Member | 15/10/2021 |
Ichnos Sciences, Inc.
 Ichnos Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ichnos Sciences, Inc. operates as a biotechnology company. It provides curative therapies that extend human life. The company was founded in 2019 and is headquartered in Paramus, NJ. | Director/Board Member | - |
| The Ragon Institute of MGH MIT & Harvard | Corporate Officer/Principal | - |
| Harvard Medical School | Corporate Officer/Principal | - |
Massachusetts General Hospital Cancer Center
 Massachusetts General Hospital Cancer Center Hospital/Nursing ManagementHealth Services Massachusetts General Hospital Cancer Center operates as cancer treatment center. The company was founded by John Warren in 1811 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
| Massachusetts Institute of Technology | Corporate Officer/Principal | - |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Anciens postes connus de Marcela Maus
| Sociétés | Poste | Fin |
|---|---|---|
| BLUEBIRD BIO, INC. | Director/Board Member | 04/11/2021 |
| CENTURY THERAPEUTICS, INC. | Founder | - |
Formation de Marcela Maus
| University of Pennsylvania | Doctorate Degree |
| Massachusetts Institute of Technology | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| CENTURY THERAPEUTICS, INC. | Health Technology |
| 2SEVENTY BIO, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Massachusetts General Hospital Cancer Center
Massachusetts General Hospital Cancer Center Hospital/Nursing ManagementHealth Services Massachusetts General Hospital Cancer Center operates as cancer treatment center. The company was founded by John Warren in 1811 and is headquartered in Boston, MA. | Health Services |
| The Ragon Institute of MGH MIT & Harvard | |
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ichnos Sciences, Inc. operates as a biotechnology company. It provides curative therapies that extend human life. The company was founded in 2019 and is headquartered in Paramus, NJ. | Commercial Services |
